Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome
Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study
Sponsor: Chengdu University of Traditional Chinese Medicine
Listed as NCT02538692, this PHASE2/PHASE3 trial focuses on Diarrhea-predominant Irritable Bowel Syndrome and remains completed. Sponsored by Chengdu University of Traditional Chinese Medicine, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
May 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chengdu University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .